An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The most common symptoms I hear from my patients are leg cramping or discomfort with walking. They often tell me they can ...

Our study thus confirmed what was found in people of African descent in the US: the genetic origin underpinning the excess ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

HONOLULU (KHON2) — Peripheral Artery Disease is a common condition ... And it most commonly affects people with diabetes, chronic kidney disease or smoking. It’s quite common here in Hawaii ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

This model exhibits ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of ...